Search all trials

Find therapies in clinical trials near you – page 30

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Migraine

Not recruiting

Registered drug

Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Rimegepant

Contact Research Centre

Crohn's disease

Not recruiting

Registered drugNo placebo

Study on Upadacitinib for Children with Moderate to Severe Crohn's Disease

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Ciprofloxacin

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Osimertinib

Contact Research Centre

Triple negative breast cancer+1

Not recruiting

Investigational

Study on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Niraparib Tosilate Monohydrate

Contact Research Centre

Bladder cancer

Not recruiting

InvestigationalNo placebo

Study on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Head and neck cancer metastatic

Not recruiting

Registered drugNo placebo

Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Eftilagimod Alfa

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

K-ras gene mutation+2

Not recruiting

Registered drugNo placebo

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Itepekimab

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Irinotecan

Contact Research Centre

Prostate cancer

Not recruiting

Registered drugNo placebo

Study on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

IgA nephropathy

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Find therapies in clinical trials near you – page 30

546 trials match your criteria

Migraine

Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

Crohn's disease

Study on Upadacitinib for Children with Moderate to Severe Crohn's Disease

Non-small cell lung cancer+1

Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

Triple negative breast cancer+1

Study on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA

Bladder cancer

Study on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment

Head and neck cancer metastatic

Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

Crohn's disease

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

K-ras gene mutation+2

Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

Chronic obstructive pulmonary disease

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Neoplasm malignant

Study of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors

Prostate cancer

Study on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients

IgA nephropathy

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.